These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4198964)

  • 1. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E; Gey KF; Sommer P
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
    Beyer J; Cordes U; Sell G; Krall H; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
    [No Abstract]   [Full Text] [Related]  

  • 4. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 6. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoglycaemic and related activities of a new pyrazolopyridine derivative (SQ 65,993).
    Polacek I; Schulze E; Burg H; Ouart J
    Arzneimittelforschung; 1974 Sep; 24(9):1242-7. PubMed ID: 4479785
    [No Abstract]   [Full Text] [Related]  

  • 10. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
    Leubner H
    Wien Med Wochenschr; 1973 Apr; 123(17):277-82. PubMed ID: 4574026
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
    Voss D; Fuchs G; Schneider D; Schneider J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2219. PubMed ID: 4679252
    [No Abstract]   [Full Text] [Related]  

  • 14. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
    Beyer J; Cordes U; Krall H; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
    Duhault J; Boulanger M; Tisserand F; Bergi L
    Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
    Alemany M; Palou A; Codina J; Herrera E
    Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
    Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
    Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
    [No Abstract]   [Full Text] [Related]  

  • 18. Glipizide: experimental study and comparison with other sulfonylureas.
    Loubatieres-Mariani MM
    Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of glibornuride (glutril): a new oral antidiabetic drug.
    van der Merwe M; van Rooyen R
    S Afr Med J; 1973 Sep; 47(36):1638-42. PubMed ID: 4746966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.